February 15, 2022
AABB is asking for input from the blood and biotherapies community as the organization plans the future of the National Blood Foundation (NBF). The National Blood Foundation, established in 1983, serves the fields of transfusion medicine and cellular therapies through grantmaking, educational offerings, and industry leadership engagement and recognition.
As part of this new chapter, AABB plans to expand the NBF’s support of the transfusion medicine and biotherapies community. AABB has designed a survey to help inform this next phase. The survey should take only a few minutes to complete and individual responses will remain confidential.